World's Best Scientists 2026 revealed!
Jacek C. Szepietowski

Jacek C. Szepietowski

D-Index & Metrics

Medicine

D-Index
84
Citations
33366
World Ranking
14912
National Ranking
17

Overview

Jacek C. Szepietowski is affiliated with Wrocław Medical University in Poland, focusing extensively on research in the field of medicine. Their work primarily addresses dermatology and related subfields, with a substantial number of publications exploring various skin diseases and treatments.

The scientist's research spans several main topics, including:

  • Dermatology and Skin Diseases
  • Hidradenitis Suppurativa and Treatments
  • Colorectal and Anal Carcinomas
  • Psoriasis: Treatment and Pathogenesis
  • Allergic Rhinitis and Sensitization
  • Urticaria and Related Conditions
  • Asthma and respiratory diseases

Szepietowski has contributed to multiple subfields of study within medicine such as:

  • Dermatology
  • Epidemiology
  • Surgery
  • Immunology and Allergy
  • Immunology

Significant publication venues for Szepietowski's work include:

  • Journal of the European Academy of Dermatology and Venereology (56 publications)
  • Acta Dermato Venereologica (45 publications)
  • Advances in Dermatology and Allergology (42 publications)
  • Journal of Clinical Medicine (33 publications)
  • Journal of the American Academy of Dermatology (32 publications)

Frequent coauthors in Szepietowski's research activity are:

  • Piotr K. Krajewski (109 joint publications)
  • Łukasz Matusiak (86 joint publications)
  • Adam Reich (57 joint publications)
  • Aleksandra Stefaniak (38 joint publications)
  • Joanna Narbutt (33 joint publications)

Among the recent papers involving or relevant to Szepietowski's domain are:

  • "European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy" (2022), published in Journal of the European Academy of Dermatology and Venereology
  • "Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial" (2022), published in Journal of the American Academy of Dermatology
  • "Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies" (2021), published in Journal of the American Academy of Dermatology
  • "European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations" (2022), published in Journal of the European Academy of Dermatology and Venereology
  • "Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial" (2023), published in The Lancet

Best Publications

  • Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

    Andrew Blauvelt;Marjolein de Bruin-Weller;Melinda Gooderham;Jennifer C. Cather

  • Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I.

    A Wollenberg;S Barbarot;T Bieber;S Christen-Zaech

  • European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

    C C Zouboulis;N Desai;L Emtestam;Robert Hunger

  • The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries

    Florence F.J. Dalgard;Uwe Gieler;Lucía Tomas-Aragones;Lars Lien

  • Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

    J. Ring;A. Alomar;T. Bieber;M. Deleuran

  • Clinical classification of itch: a position paper of the International Forum for the Study of Itch.

    Sonja Ständer;Elke Weisshaar;Thomas Mettang;Jacek C. Szepietowski

  • Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.

    Diamant Thaçi;Eric L Simpson;Lisa A Beck;Thomas Bieber

  • Itch: scratching more than the surface.

    R Twycross;M W Greaves;H Handwerker;E A Jones

  • Visual analogue scale: evaluation of the instrument for the assessment of pruritus.

    Adam Reich;Monika Heisig;Ngoc Quan Phan;Kenichi Taneda

  • European S2k Guideline on Chronic Pruritus.

    Elke Weisshaar;Jacek C Szepietowski;Florence J Dalgard;Simone Garcovich

  • Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.

    C. C. Zouboulis;T. Tzellos;A. Kyrgidis;G. B. E. Jemec

  • Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus.

    Ngoc Quan Phan;Christine Blome;Fleur Fritz;Joachim Gerss

  • Diagnostic delay in hidradenitis suppurativa is a global problem.

    D.M. Saunte;J. Boer;A. Stratigos;J.C. Szepietowski

  • Psychophysical aspects of hidradenitis suppurativa.

    Lukasz Matusiak;Andrzej Bieniek;Jacek C Szepietowski

  • Patients with psoriasis feel stigmatized.

    Ewa Hrehorów;Joanna Salomon;Lukasz Matusiak;Adam Reich

  • Hidradenitis suppurativa markedly decreases quality of life and professional activity.

    Łukasz Matusiak;Andrzej Bieniek;Jacek C. Szepietowski;Jacek C. Szepietowski

  • Pruritus is an important factor negatively influencing the well-being of psoriatic patients.

    Adam Reich;Ewa Hrehorów;Jacek C Szepietowski

  • Uremic pruritus: a clinical study of maintenance hemodialysis patients.

    Jacek C. Szepietowski;Magdalena Sikora;Mariusz Kusztal;Joanna Salomon

  • Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE)

    Ulrich Mrowietz;Craig L. Leonardi;Giampiero Girolomoni;Darryl Toth

  • Psoriatic Nails: A Prospective Clinical Study

    Joanna Salomon;Jacek C. Szepietowski;Alina Proniewicz

Frequent Co-Authors

Gregor B. E. Jemec
Gregor B. E. Jemec University of Copenhagen
Andrea W M Evers
Andrea W M Evers Leiden University
Andrew Yule Finlay
Andrew Yule Finlay Cardiff University
Matthias Augustin
Matthias Augustin Universität Hamburg
Christos C. Zouboulis
Christos C. Zouboulis Medizinische Hochschule Brandenburg Theodor Fontane
Eric L. Simpson
Eric L. Simpson Oregon Health & Science University
Robert A. Schwartz
Robert A. Schwartz Rutgers, The State University of New Jersey
Martin Metz
Martin Metz Charité - University Medicine Berlin
Martin Dugas
Martin Dugas Heidelberg University
Victoria P. Werth
Victoria P. Werth University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in exploring flexible healthcare career options, online degrees offer practical pathways into the medical field. For those who want a non-clinical yet vital role, earning a certification in medical billing and coding certification cost is relatively affordable and allows you to work in healthcare administration from anywhere.

Aspiring nurses have a range of choices with programs that fit various budgets. You can find one of the most affordable nurse practitioner programs online, or complete your nursing degree online to become a registered nurse, which opens doors to diverse specializations.

For career advancement or leadership roles, consider pursuing an online nursing doctorate. These flexible programs are ideal for working professionals looking to move into research, policy, or academic positions within healthcare.

Best Scientists Citing Jacek C. Szepietowski

Trending Scientists